Sanofi

Equities

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 09:25:00 11/07/2025 pm IST			5-day change	1st Jan Change
83.03 ^EUR	-1.34%		-0.31%	-11.43%

11/07	SANOFI : UBS reiterates its Buy rating	ZD
11/07	Delaware Supreme Court sides with Zantac drugmakers over cancer evidence	RE

Sanofi Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 04:00 PM

Published on 11/06/2025 at 05:35, updated on 11/06/2025 at 06:36

Presenter Speech
James Quigley (Analysts)

Excellent. So welcome, everybody. I'm James Quigley from Goldman Sachs. I'm the European pharma analyst, and it's a pleasure to welcome you all to this session

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Sanofi

SANOFI : UBS reiterates its Buy rating	11/07	ZD
Delaware Supreme Court sides with Zantac drugmakers over cancer evidence	11/07	RE
Delaware Supreme Court sides with Zantac drugmakers over evidence	11/07	RE
Nurix Therapeutics Fiscal Q2 Loss Narrows, Revenue More Than Triples; Shares Surge Premarket	10/07	MT
SANOFI : UBS maintains a Buy rating	08/07	ZD
SANOFI : Goldman Sachs reiterates its Neutral rating	03/07	ZD
Berenberg Keeps Sanofi at Buy on Expanding Pipeline Optionality	03/07	MT
SANOFI : Gets a Buy rating from Berenberg	03/07	ZD
AlphaValue/Baader Europe Cuts Sanofi Price Target Amid Pipeline Setbacks, Leadership Concerns	02/07	MT
SANOFI : Barclays keeps its Buy rating	02/07	ZD
SANOFI : JP Morgan remains Neutral	02/07	ZD
SANOFI : Pipeline disappointments may push out the CEO	01/07
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	01/07	MT
Adagene ADRs Rise Following Sanofi Investment	01/07	DJ
Adagene to Receive up to $25 Million Investment From Sanofi; Shares up Pre-Bell	01/07	MT
SANOFI : UBS reaffirms its Buy rating	01/07	ZD
Euroapi: sells Haverhill site in UK	01/07	CF
Esteve Pharmaceuticals, S.A. agreed to acquire Caprelsa® rights in more than 50 countries from Sanofi.	01/07	CI
Sanofi Advances Rare Neurological Disorder Treatment with Orphan Drug Status in Japan	30/06	MT
Sanofi Announces Riliprubart Granted Orphan Drug Designation in Japan for Chronic Inflammative Demyelinating Polyneuropathy	30/06	CI
Sanofi: riliprubart designated orphan drug in Japan	30/06	CF
Sanofi's Riliprubart Secures Orphan Drug Designation in Japan	30/06	MT
Kennedy's US vaccine panel backs preservative-free shot despite safety evidence	27/06	RE
Pfizer's bleeding disorder therapy succeeds in trial with patients with certain antibodies	26/06	RE
US CDC vaccine panel postpones vote on RSV therapies	26/06	RE